Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Genomics-Driven Drug Trials Built To Be Fast And Flexible

This article was originally published in The Gray Sheet

Executive Summary

Pioneering next-generation sequencing enrollment strategies are coupled with adaptive statistical designs in the next wave of drug "basket" trials from NCI, ASCO and Novartis.


Related Content

Roche's Oncology Strategy: The Long Game Comes Into Focus
Lung-MAP Patient Screening Should Translate To Cost-Savings


Related Companies